Bosutinib (BOS) Versus Imatinib for Newly Diagnosed Chronic Phase (CP) Chronic Myeloid Leukemia (CML): Final 5-Year Results from the Bfore Trial
暂无分享，去创建一个
T. Brümmendorf | R. Clark | J. Cortes | M. Deininger | C. Chuah | J. Lipton | M. Mauro | P. Rousselot | E. Leip | C. Gambacorti-Passerini | A. Hochhaus | S. Purcell | V. Kota | A. Yver | A. Viqueira | V. García‐Gutiérrez | Rafael Hurtado Monroy | D. Milojkovic | Philipp le Coutre | P. L. Coutre